In total, 17% of patients experienced adverse drug reactions, again mostly fever, headache, pain, back pain, and nausea, though 5% had persistent pain and allodynia lasting greater than 2 weeks [165]
Ongoing Care After approval, your provider stays reachable through the apps chat, though live provider involvement is limited
The answer depends on whether youll inject subcutaneously (SQ) or intramuscularly (IM)
The change in body weight from baseline was 13.3% and 2.6% in the semaglutide and placebo groups, respectively
Natural Science Foundation of Chongqing (grant number is CSTB2024NSCQ-MSX0027)
Measure and document the BMI at each encounter